This Event has now run. Thank You to our Speakers, Sponsors, and Delegates who joined us in Boston for the Summit!
Driving Potency, Efficacy & Durability of Universal Cell Therapies
The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as reduced cost, production and patient accessibility compared to its autologous counterparts.
Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th Annual Allogeneic Cell Therapies Summit returned to Boston in June as the leading industry focused meeting dedicated to accelerating the safety, durability and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.
Across a jam-packed agenda consisting of 60+ hours of content and 3 in-depth tracks, 50+ expert speakers led you discussions to help to transform universal cell therapies for patients across the globe.
Pre-Clinical Track
Clinical Track
Manufacturing & Process Development Track
60+
Hours of Content
3
In-Depth Tracks
50+
Expert Speakers
14
BESPOKE PARTNERS
12+
New Speaking Companies
2
Conference
Days
2024 World Class Speaker Faculty Included:
Colleen Delaney
Founder and Chief Scientific Officer, EVP of Research and Development
Deverra Therapeutics
"The networking opportunities are great. I get the chance to talk to many people in this field and get to know some key players. Talks are relevant and informative”
Stemcell Technologies
Who Attended in 2024?
"Was great to meet Chief Scientific Officers and other high-level management from multiple companies”
Poseida Therapeutics